sexta-feira, 14 de agosto de 2026
PesquisarExplore
Factos em que pode confiar·101 entities·4,772 factos com fonte
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· May 24, 2026

Better Health Care ETF: Fidelity's FHLC vs. State Street's XLV

View original at finance.yahoo.com
Better Health Care ETF: Fidelity's FHLC vs…
Opening lines of the source · short snapshot — read the full document at the original

O que extraímos desta fonte

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • XLV has paid $2.51 per share in distributions over the trailing 12 months, with a dividend yield of 1.7% versus FHLC's 1.4%

    60% confidence
  • XLV offers superior liquidity and a higher trailing-12-month dividend yield compared to FHLC, making it more suitable for income-seeking investors

    60% confidence
  • XLV generated a growth of $1,284 from a $1,000 investment over five years on a total return basis, outperforming FHLC's $1,231 over the same period despite lower 1-year return

    60% confidence
  • FHLC has a trailing-12-month dividend of $1.01 per share, and its broader MSCI-based index captures small- and mid-cap companies that XLV skips

    60% confidence
  • FHLC provides broader market-cap exposure including mid- and small-cap stocks, capturing companies that XLV skips by tracking only S&P 500 healthcare components

    60% confidence

Data points we hold from this source

Johnson & Johnson Services, Inc. · portfolio weight in xlv10.42 percent
Johnson & Johnson Services, Inc. · portfolio weight in fhlc8.90 percent
Eli Lilly and Company · portfolio weight in fhlc13.16 percent
Eli Lilly and Company · portfolio weight in xlv15.18 percent
AbbVie Inc. · portfolio weight in xlv7.09 percent
AbbVie Inc. · portfolio weight in fhlc6.06 percent
Better Health Care ETF: Fidelity's FHLC vs. State Street's XLV — Source | Via News | pt.VIA.NEWS